Publication: Non-A, Non-B/C Hepatitis
| dc.contributor.author | Durupinar B. | |
| dc.date.accessioned | 2020-06-21T09:20:04Z | |
| dc.date.available | 2020-06-21T09:20:04Z | |
| dc.date.issued | 1993 | |
| dc.department | OMÜ | en_US |
| dc.department-temp | Durupinar, B., Ondokuzmayis Universitesi, Tip Fakültesi Mikrobiyoloji Anabilim Dali., Turkey -- | en_US |
| dc.description.abstract | A recombinant immunoscreening approach was used to clone and identified the genome of the non-A, non-B hepatitis virus. This agent is a positive-stranded RNA virus that appears to be distantly related to the flaviviridae family. A recombinant viral antigen (C100-3) was used to develop a "capture" assay for circulating antibody. Data obtained using this assay indicate that this agent, termed the Hepatitis C virus (HCV), is the major cause of post-transfusion, community-acquired and cryptogenic, NANB. HCV is associated with the development of hepatocellular carcinoma and possibly, other liver diseases. In this article the characteristic of Hepatitis C virus were discussed. | en_US |
| dc.identifier.endpage | 265 | en_US |
| dc.identifier.issn | 0374-9096 | |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.pmid | 7689690 | |
| dc.identifier.startpage | 259 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/3218 | |
| dc.identifier.volume | 27 | en_US |
| dc.language.iso | tr | en_US |
| dc.relation.journal | Mikrobiyoloji bülteni | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Non-A, Non-B/C Hepatitis | en_US |
| dc.title.alternative | Non-A, non-B/C hepatiti. | en_US |
| dc.type | Review | en_US |
| dspace.entity.type | Publication |